Beijing Scitop Bio-Tech released a summary of its 2024 interim report. During the reporting period, the company achieved a revenue of CNY 138.0509 million, a YoY decrease of 1.34%; and a net income attributable to the parent company's owners of CNY 43.515 million, a YoY increase of 7.89%.
科拓生物：上半年净利润同比增长7.89%
Beijing Scitop Bio-Tech: Net income increased by 7.89% YoY in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated